Gaffin David Joseph

Avg. Two Year Performance

No purchase track record
5% Avg. Sale Return
3% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return2%(< 1%)(< 1%)4%5%
Sale Success Rate3 of 51 of 51 of 51 of 52 of 5

Alkermes Plc.

Drugs » Drug Delivery

EVP, CLO, Alkermes, Inc.:

Holdings: 164.78K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--